IVOG Strangle Strategy
IVOG (Vanguard S&P Mid-Cap 400 Growth ETF), in the Financial Services sector, (Asset Management - Global industry), listed on AMEX.
The Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) allocates its capital to equities within the S&P MidCap 400 Growth Index, which is specifically designed to encompass growth-oriented companies drawn from the broader S&P 400. Its central objective is to meticulously replicate the performance of this index, which serves as a recognized benchmark for the overall U.S. mid-capitalization growth stock market. This fund offers considerable upside potential for capital appreciation, though its share value tends to fluctuate more dramatically than that of bond-focused investments. Consequently, it is best suited for individuals pursuing long-term financial goals where significant growth of their principal is paramount. It is noteworthy that on March 14, 2023, this ETF executed a 2-for-1 share split, which led to a reduction in its per-share price and a corresponding increase in the number of shares outstanding. Unless specifically noted as market data, historical share price information has not been retrospectively adjusted for this corporate action.
IVOG (Vanguard S&P Mid-Cap 400 Growth ETF) trades in the Financial Services sector, specifically Asset Management - Global, with a market capitalization of approximately $1.82B, a beta of 1.08 versus the broader market, a 52-week range of 112.5-145.81, average daily share volume of 30K, a public-listing history dating back to 2010. These structural characteristics shape how IVOG etf options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.08 places IVOG roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. IVOG pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on IVOG?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current IVOG snapshot
As of June 29, 2026, spot at $143.88, ATM IV 17.60%, IV rank 24.22%, expected move 5.05%. The strangle on IVOG below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this strangle structure on IVOG specifically: IVOG IV at 17.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a IVOG strangle, with a market-implied 1-standard-deviation move of approximately 5.05% (roughly $7.26 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IVOG expiries trade a higher absolute premium for lower per-day decay. Position sizing on IVOG should anchor to the underlying notional of $143.88 per share and to the trader's directional view on IVOG etf.
IVOG strangle setup
The IVOG strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IVOG near $143.88, the first option leg uses a $149.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IVOG chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IVOG shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $149.00 | $0.39 |
| Buy 1 | Put | $137.00 | $0.53 |
IVOG strangle risk and reward
- Net Premium / Debit
- -$92.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$92.00
- Breakeven(s)
- $136.13, $149.90
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
IVOG strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on IVOG. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$13,607.00 |
| $31.82 | -77.9% | +$10,425.84 |
| $63.63 | -55.8% | +$7,244.69 |
| $95.44 | -33.7% | +$4,063.53 |
| $127.26 | -11.6% | +$882.38 |
| $159.07 | +10.6% | +$914.78 |
| $190.88 | +32.7% | +$4,095.93 |
| $222.69 | +54.8% | +$7,277.09 |
| $254.50 | +76.9% | +$10,458.25 |
| $286.31 | +99.0% | +$13,639.40 |
When traders use strangle on IVOG
Strangles on IVOG are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the IVOG chain.
IVOG thesis for this strangle
The market-implied 1-standard-deviation range for IVOG extends from approximately $136.62 on the downside to $151.14 on the upside. A IVOG long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current IVOG IV rank near 24.22% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IVOG at 17.60%. As a Financial Services name, IVOG options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IVOG-specific events.
IVOG strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IVOG positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IVOG alongside the broader basket even when IVOG-specific fundamentals are unchanged. Always rebuild the position from current IVOG chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on IVOG?
- A strangle on IVOG is the strangle strategy applied to IVOG (etf). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With IVOG etf trading near $143.88, the strikes shown on this page are snapped to the nearest listed IVOG chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are IVOG strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the IVOG strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 17.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$92.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IVOG strangle?
- The breakeven for the IVOG strangle priced on this page is roughly $136.13 and $149.90 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IVOG market-implied 1-standard-deviation expected move is approximately 5.05%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on IVOG?
- Strangles on IVOG are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the IVOG chain.
- How does current IVOG implied volatility affect this strangle?
- IVOG ATM IV is at 17.60% with IV rank near 24.22%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.